PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling

BACKGROUND: Peroxiredoxin 1 (PRDX1) has been identified as a dual regulator of tumorigenesis. However, its expression, clinical significance, and biological function in nasopharyngeal carcinoma (NPC) remain unknown. This study aimed to explore the role and underlying mechanisms of PRDX1 in NPC. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Hongmei, Yang, Taoyu, Yan, Lingli, Feng, Jihong, Huang, Boyan, Jiang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501964/
https://www.ncbi.nlm.nih.gov/pubmed/32982301
http://dx.doi.org/10.2147/OTT.S252286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501964/
https://www.ncbi.nlm.nih.gov/pubmed/32982301
http://dx.doi.org/10.2147/OTT.S252286

Ejemplares similares